SKI Market

Indian Indices

Nifty

25,910.05 30.90
(0.12%)

Sensex

84,562.78 84.11
( 0.10%)

Bank Nifty

58,517.55 135.60
( 0.23%)

Nifty IT

36,301.25 -378.20
( -1.03%)

Global Indices

Nasdaq

47,163.83 -314.39
(-0.66%)

Dow Jones

6,754.35 -4.14
(-0.06%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,693.83 -113.85
(-1.16%)

Forex

USD-INR

88.71 0.12
(0.13%)

EUR-INR

103.04 0.44
(0.43%)

GBP-INR

116.72 0.41
(0.35%)

JPY-INR

0.57 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Brooks Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533543

INE650L01011

39.0633056

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BROOKS

53.18

314.9

EPS(TTM)

Face Value()

Div & Yield %

2.01

Back

Cholamandalam Investment & Finance Company consolidated net profit rises 19.82% in the September 2025 quarter

Nov 06,2025

Net profit of Cholamandalam Investment & Finance Company rose 19.82% to Rs 1159.61 crore in the quarter ended September 2025 as against Rs 967.80 crore during the previous quarter ended September 2024. Sales rose 19.76% to Rs 7491.38 crore in the quarter ended September 2025 as against Rs 6255.12 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7491.38	6255.12	20
OPM %	67.16	69.67	-
PBDT	1636.94	1367.51	20
PBT	1565.91	1304.88	20
NP	1159.61	967.80	20

25,910.05 30.90 (0.12%)

84,562.78 84.11 ( 0.10%)

58,517.55 135.60 ( 0.23%)

36,301.25 -378.20 ( -1.03%)

47,163.83 -314.39 (-0.66%)

6,754.35 -4.14 (-0.06%)

50,333.56 -948.27 (-1.85%)

9,693.83 -113.85 (-1.16%)

88.71 0.12 (0.13%)

103.04 0.44 (0.43%)

116.72 0.41 (0.35%)

0.57 0.00 (0.16%)